The loss of urokinase plasminogen activator receptor (uPAR) and integrin β1 (intβ1) increase the dormant tumor state reducing invasiveness and metastasis potential and expanding the phenotype of the dormant disseminated tumor cells (DTCs) and CSCs [53]. This evidence concerns the gene PLAUR and neoplasm.